MARTIN SADOWSKI, M.D.
Neurology at 34 St, New York, NY
License number
New York 224363
Category
Neurology
Type
Neurology
Address
Address
400 E 34Th St, New York, NY 10016
Phone
(212) 263-2152
Personal information
See more information about MARTIN SADOWSKI at radaris.comName
Address
Phone
6298 Saunders St APT 6E, Rego Park, NY 11374
6298 Saunders St, Rego Park, NY 11374
Professional information
Martin Sadowski, New York NY
Specialties:
Neurology
Work:
Rusk Institute
400 E 34Th St, New York, NY 10016 Manhattan Campus of the VA NY Harbor Healthcare System
423 E 23Rd St, New York, NY 10010 NYU Hospitals Center
550 1St Ave, New York, NY 10016 New York University
240 E 38Th St, New York, NY 10016
400 E 34Th St, New York, NY 10016 Manhattan Campus of the VA NY Harbor Healthcare System
423 E 23Rd St, New York, NY 10010 NYU Hospitals Center
550 1St Ave, New York, NY 10016 New York University
240 E 38Th St, New York, NY 10016
Education:
Akademia Medyczna, Gdansk (1995)
Independent Health, Wellness And Fitness Professional
Location:
Greater New York City Area
Pyridyl-2-Methylamino Compounds, Compositions And Uses Thereof
US Patent:
2013007, Mar 28, 2013
Filed:
Jul 6, 2012
Appl. No.:
13/543760
Inventors:
Bijan Almassian - Cheshire CT, US
Martin J. Sadowski - New York NY, US
Xu Kevin Lin - Branford CT, US
Martin J. Sadowski - New York NY, US
Xu Kevin Lin - Branford CT, US
International Classification:
C07D 235/30, C07D 213/53, C07D 213/38
US Classification:
514357, 546334, 5483074, 514395
Abstract:
Compounds are provided according to formula I:where R, R′, R, R, R, and Rare as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, Alzheimer' s Disease, Down's syndrome, Parkinson's Disease, and others.
Peptoid And Synthetic Oligomers, Pharmaceutical Compositions And Methods Of Using Same
US Patent:
2012001, Jan 19, 2012
Filed:
Jun 9, 2011
Appl. No.:
13/134547
Inventors:
Martin J. Sadowski - New York NY, US
Kent Kirshenbaum - New York NY, US
Kent Kirshenbaum - New York NY, US
International Classification:
A61K 38/08, A61P 25/28, C07K 7/06
US Classification:
514 177, 530329
Abstract:
Novel peptide/peptoid oligomers are disclosed that have a formula represented by the following formula Ia or Ib:The peptide/peptoid oligomers demonstrate the ability to inhibit fibrillization and oligomerization of Aβ and may be prepared as pharmaceutical compositions and used for the prevention or treatment of a variety of conditions in mammals, including humans, associated with Aβ oligomerization. The present peptidomimetic oligomers are particularly valuable for the treatment of subjects with AD.